Ikeda, Japan

Takashi Higo

This inventor holds 1 USPTO granted patent. Top assignee: Astra Aktiebolag. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Higo. Retrieved from https://idiyas.com/inventor/takashi-higo-83ijm523

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Higo: Innovator in Pharmaceutical Technology

Introduction

Takashi Higo is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly through his innovative work on drug formulations.

Latest Patents

Higo holds a patent for an injection and injection kit containing omeprazole and its analogs. This invention is crucial for the delivery of medication, enhancing the efficacy of treatment options available for patients.

Career Highlights

Currently, Takashi Higo is associated with Astra Aktiebolag, a prominent company in the pharmaceutical industry. His work at Astra has allowed him to focus on developing advanced medical solutions that address various health challenges.

Collaborations

Throughout his career, Higo has collaborated with esteemed colleagues such as Shigeo Nakanishi and Tetsuo Tominaga. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Takashi Higo's contributions to pharmaceutical technology exemplify the impact of dedicated inventors in the medical field. His work continues to influence the development of effective treatment options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…